A Close Look at Valuations Of Bellicum Pharmaceuticals, Inc. (BLCM), Annaly Capital Management, Inc. (NLY – Post Analyst

This post was originally published on this site

A Close Look at Valuations Of Bellicum Pharmaceuticals, Inc. (BLCM), Annaly Capital Management, Inc. (NLY  Post Analyst

Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) current P/S is an unimpressive 1169.61. The overall Biotechnology group has an average P/S ratio of 49.5, …

This post was originally published on *this site*